Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10

Company Participation in Conference - Anixa Biosciences will participate in the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10th and 11th, 2024 [1] - Dr Amit Kumar, CEO of Anixa, is scheduled to present on December 10th at 2:00 pm Eastern Standard Time [2] - Management will be available for one-on-one meetings with approved qualified investors on December 11th [2] Conference Details - iAccess Alpha hosts virtual investor conferences where presenting companies are recommended by a network of investors [3] - The conference format includes company webcast presentations on day one and one-on-one meetings with company management teams on day two [3] Company Overview - Anixa Biosciences is a clinical-stage biotechnology company focused on the treatment and prevention of cancer [4] - The company's therapeutic portfolio includes an ovarian cancer immunotherapy program developed in collaboration with Moffitt Cancer Center, using CER-T technology [4] - Anixa's vaccine portfolio includes vaccines developed with Cleveland Clinic to treat and prevent breast cancer and ovarian cancer, as well as additional cancer vaccines targeting lung, colon, and prostate cancers [4] - The company's business model involves partnering with world-renowned research institutions for development and commercialization of emerging technologies [4]